BSEM

BioStem Technologies Inc. (BSEM)

Stock · NASDAQ

$2.09as of 10/16/2026

Price chart

Open in TradingView

Active signals

No technical signal is currently active for this symbol.

Resistance level
$3.58

About BSEM

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje…

Employees
73

Fundamentals

1-day range
$2.36$2.76
Market cap
$—
P/E (trailing)
—
P/E (forward)
9.10
EPS (trailing)
$-1.20
Dividend yield
—
Beta
0.53
Avg. volume
124.1K
52-week range
$2.25$8.4
Next earnings: November 12, 2026 · EPS estimate $0.10confirmed

Forecasts

1 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$7
+234.9%
Median
$7
+234.9%
Low
$7
+234.9%

Latest news

Insider Activity

Insider Actions →
Acquired
95.8K
Disposed
0

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.